Search research articles
Contact Us
Filters
Showing results (11-20 of 15) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 15 results.
Journal of Histotechnology
|
March 18, 2024
Survey of NAACLS accredited histotechnology programs in the United States
Carol Bain, Debra Wood, Sheila Criswell
Behavioral Sciences & the Law
|
September 13, 2008
Drug-associated psychoses and criminal responsibility
Andrew Carroll, Bernadette McSherry, Debra Wood, et al.
Journal of Women'S Health (2002)
|
July 9, 2013
Role of environment and sex differences in the development of autoimmune diseases: a roundtable meeting report
Monica P Mallampalli, Erika Davies, Debra Wood, et al.
Cancer Chemotherapy and Pharmacology
|
December 7, 2006
Erlotinib plus gemcitabine in patients with unresectable pancreatic cancer and other solid tumors: phase IB trial
Tomislav Dragovich, Mark Huberman, Daniel D Von Hoff, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 26, 2006
Phase I, pharmacokinetic, and biological study of erlotinib in combination with paclitaxel and carboplatin in patients with advanced solid tumors
Amita Patnaik, Debra Wood, Anthony W Tolcher, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 15) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 15 results.
Journal of Histotechnology
|
March 18, 2024
Survey of NAACLS accredited histotechnology programs in the United States
Carol Bain, Debra Wood, Sheila Criswell
Behavioral Sciences & the Law
|
September 13, 2008
Drug-associated psychoses and criminal responsibility
Andrew Carroll, Bernadette McSherry, Debra Wood, et al.
Journal of Women'S Health (2002)
|
July 9, 2013
Role of environment and sex differences in the development of autoimmune diseases: a roundtable meeting report
Monica P Mallampalli, Erika Davies, Debra Wood, et al.
Cancer Chemotherapy and Pharmacology
|
December 7, 2006
Erlotinib plus gemcitabine in patients with unresectable pancreatic cancer and other solid tumors: phase IB trial
Tomislav Dragovich, Mark Huberman, Daniel D Von Hoff, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 26, 2006
Phase I, pharmacokinetic, and biological study of erlotinib in combination with paclitaxel and carboplatin in patients with advanced solid tumors
Amita Patnaik, Debra Wood, Anthony W Tolcher, et al.
Page
of 2